GlycoSurf supplies high‑purity (≥95%) glycolipid and rhamnolipid surfactants derived from renewable sugars, offering biodegradable, non‑toxic alternatives to conventional surfactants.
Funding
$206.2K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Formulators in cleaning, personal care, textiles, plastics, oilfield chemicals, agriculture, and food industries often rely on conventional surfactants that are toxic, non‑biodegradable, and limited in performance customization, creating environmental and regulatory challenges.
Solution
GlycoSurf produces high‑purity (≥95%) glycolipid and rhamnolipid surfactants derived from renewable sugars. Their bio‑inspired molecules are biodegradable, non‑toxic, and available with a range of sugar head‑groups and tail‑chain lengths (C8‑C18, single or double chain). This enables customers to select surfactants that meet specific performance criteria while reducing ecological impact. The scalable synthetic process ensures consistent quality and allows custom synthesis for niche applications. Products are sold directly to formulators, who can integrate them into formulations for enhanced wetting, cleaning, emulsification, or biofilm disruption.
Target Audience
Primary customers are formulators and product developers in cleaning, personal care, textile, plastics, oilfield, agricultural, and food industries seeking sustainable, high‑performance surfactants.
Features
- Glycolipid and rhamnolipid surfactants with >95% purity for reliable performance
- Multiple sugar head‑groups (glucose, galactose, xylose, etc.) and tail‑chain options (C8‑C18, single or double chain)
- Fully biodegradable and non‑toxic, meeting green chemistry standards
- Scalable synthetic process supporting bulk production and custom molecule design
- High efficacy in cleaning, personal care, textiles, plastics, oilfield chemicals, agriculture, and food emulsification
- Compatibility with existing formulation processes and regulatory compliance